(HealthDay)—Tretten (coagulation factor XIII A-Subunit recombinant) has been approved by the U.S. Food and Drug Administration to treat a very rare blood clotting disorder called congenital Factor XIII A-Subunit deficiency.
Dec 23, 2013
Las Vegas public health officials say dozens of people linked to a tuberculosis outbreak at a neonatal unit have tested positive for the disease.
Dec 23, 2013
US President Barack Obama has symbolically signed up for health insurance to promote his own controversial health care reform legislation, a White House official said Monday.
Dec 23, 2013
A systematic review of 66 research papers focused on the treatment of skin ulcers suggests that most are so technically flawed that their results are unreliable. And even of those that pass muster, there is only weak evidence ...
Dec 23, 2013
An antibody that blocks a component of a key signaling pathway in the respiratory airways could help the immune system rid the body of the influenza virus, a new study suggests. The findings, from a team at The Research Institute ...
Dec 23, 2013
